Fast-Growing Chain of Labs, Medytox Diagnostics, Announces CEO of Laboratories

WEST PALM BEACH, FL--(Marketwired - Dec 17, 2014) - Medytox Diagnostics, Inc., which owns and operates half a dozen clinical laboratories throughout the U.S., announced today it named William DePond, M.D., CEO of Medytox laboratories. In his role, Dr. DePond will oversee the company's expanding network of toxicology labs that specialize in drug screening and analysis for substance abuse facilities and the ongoing drug screening required for patients of pain management physicians.

In addition to his operational oversight, Dr. DePond, also COO of Medytox Diagnostics, Inc., will play a key role in identifying additional labs as targets for Medytox Diagnostics' acquisition and work to upgrade information technology, including the implementation of proprietary software developed by a sister company, Medytox Information & Technology, Inc. Both companies are subsidiaries of Medytox Solutions, Inc. (OTCBB: MMMS), a diversified healthcare company that owns and operates lab and health IT companies.

Dr. DePond, a fellowship-trained pathologist with board-certification in multiple fields of pathology, brings a physician's perspective to Medytox Diagnostics as well as decades of management experience running healthcare delivery companies. Prior to his role at Medytox, he worked on the executive leadership teams of hospital systems, multispecialty physician organizations, long-term care facilities, and another publically traded commercial laboratory company.

"William knows our business," said Seamus Lagan, CEO of Medytox Solutions, Inc. "He not only understands the mindset of the doctors and other clinicians we serve, but he has real-world experience running fast-growing companies in many facets of the healthcare industry. He has already proven himself as a valuable part of the team that is transforming Medytox into an important player among the lab testing and health technology sector."

"I've spent the better part of my career seeking to improve health outcomes for patients by using data and technology," said Dr. DePond. "Now, at Medytox, I have the unique opportunity to apply my passions for informatics, wellness, and disease prevention at a company that is bringing improved technology to new parts of the healthcare industry."

Dr. DePond earned his medical degree at the University of Missouri at Kansas City Medical School and trained at Cedars-Sinai Medical Center in Los Angeles. He currently lives in West Palm Beach, Fla.

About Medytox Solutions, Inc. Medytox (OTCBB: MMMS) is a holding company that owns and operates businesses in the medical services sector, including clinical laboratory blood and urine testing services. It operates six laboratories throughout the U.S. with a particular emphasis in the provision of drug toxicology and monitoring pain medication utilization. Clients include physicians, clinics and rehabilitation facilities throughout the United States.